Search Filters

Search Results

Found 5 results

510(k) Data Aggregation

    K Number
    K162294
    Device Name
    BRIGHTWAY BRAND NITRILE EXAMINATION GLOVES 12”, POWDER FREE, [PURPLE] TESTED FOR USE WITH CHEMOTHERAPY DRUGS
    Manufacturer
    BRIGHTWAY HOLDINGS SDN BHD.
    Date Cleared
    2017-04-21

    (249 days)

    Product Code
    LZA, LZC
    Regulation Number
    880.6250
    Why did this record match?
    Applicant Name (Manufacturer) :

    BRIGHTWAY HOLDINGS SDN BHD

    AI/MLSaMDIVD (In Vitro Diagnostic)TherapeuticDiagnosticis PCCP Authorized
    Intended Use
    BRIGHTWAY BRAND NITRILE EXAMINATION GLOVES 12", POWDER FREE, [PURPLE] TESTED FOR USE WITH CHEMOTHERAPY DRUGS is a disposable device intended for medical purpose, to be worn on the examiners hand or finger to prevent contamination between patient and examiner. The tested chemotherapy drugs and their breakthrough detection times are as follows: • Arsenic Trioxide (0.1mg/ml),(100ppm) >240 Minutes • Bleomycin Sulfate (15mg/ml),(15,000 ppm) >240 Minutes • Busulfan(6mg/ml),(6,000 ppm) >240 Minutes • Carmustine (BCNU) (3.3mg/ml),(3,300 ppm) 127.5 Minutes • Cisplatin (1.0mg/ml), (1,000 ppm) >240 Minutes • Cyclophosphamide/Cytoxan(20mg/ml), (20,000 ppm) >240 Minutes • Cytarabine(100mg/ml), (100,000 ppm) >240 Minutes • Dacarbazine(DTIC) 10mg/ml, (10,000 ppm) >240 Minutes • Daunorubicin(5mg/ml), (5,000 ppm) >240 Minutes • Docetaxel(10mg/ml), (10,000 ppm) >240 Minutes • Doxorubicin HCL(2mg/ml),(2,000 ppm) >240 Minutes • Ellence (2mg/ml), (2,000 ppm) >240 Minutes • Etoposide /Toposar (20mg/ml), (20,000 ppm) >240 Minutes • Fludarabine (25mg/ml), (25,000 ppm) >240 Minutes • Fluorouracil(50mg/ml), (50,000 ppm) >240 Minutes • Gemcitabine/Gemzar (38mg/ml), (38,000 ppm) >240 Minutes • Idarubicin (1.0mg/ml), (1,000 ppm) >240 Minutes • Ifosfamide (50mg/ml), (50,000 ppm) >240 Minutes • Irinotecan(20mg/ml), (20,000 ppm) >240 Minutes • Mechlorethamine HCI(1.0mg/ml), (1,000 ppm) >240 Minutes • Melphalan(5mg/ml), (5,000 ppm) >240 Minutes • Methotrexate(25mg/ml),(25,000 ppm) >240 Minutes • Mitomycin C(0.5 mg/ml), (500 ppm) >240 Minutes • Mitoxantrone(2mg/ml),(2,000 ppm) >240 Minutes • Paclitaxel(6.0mg/ml),(6,000 ppm) >240 Minutes • Paraplatin (10mg/ml),(10,000 ppm) >240 Minutes • Rituximab(10mg/ml),(10,000 ppm) >240 Minutes • Thiotepa (10mg/ml),(10,000 ppm) >240 Minutes • Trisenox(0.1mg/ml), (100 ppm) >240 Minutes • Vincristine Sulfate(1.0mg/ml).(1.000 ppm) >240 Minutes Please note that the following drug noted permeation times below 240 mins: Carmustine (BCNU) 127.50 mins.
    Device Description
    The subject device in this 510(k) Notification is a Purple Nitrile Examination gloves, tested for use with Chemotherapy drugs. The subject device is a patient examination glove made from nitrile compound, Purple in color, powder free and non sterile (as per 21 CFR 880.6250, class I). The principle operation of the medical device to provide single use barrier protection for the wearer and the device meets all the requirement specifications for Barrier Protection, tensile properties as defined in ASTM D6319-10, Standard specification for Nitrile Examination Gloves. This device also complies with requirements for Standard Practice for Assessment of Resistance of Medical Gloves to Permeation by Chemotherapy drugs as per ASTM D6978-05
    Ask a Question
    K Number
    K162186
    Device Name
    BRIGHTWAY BRAND NITRILE EXAMINATION GLOVES 12”, POWDER FREE, [STERLING/GREY] WITH CHEMOTHERAPY CLAIM
    Manufacturer
    BRIGHTWAY HOLDINGS SDN BHD
    Date Cleared
    2017-03-31

    (239 days)

    Product Code
    LZC, LZA
    Regulation Number
    880.6250
    Why did this record match?
    Applicant Name (Manufacturer) :

    BRIGHTWAY HOLDINGS SDN BHD

    AI/MLSaMDIVD (In Vitro Diagnostic)TherapeuticDiagnosticis PCCP Authorized
    Intended Use
    BRIGHTWAY BRAND NITRILE EXAMINATION GLOVES 12", POWDER FREE, [STERLING/GREY] WITH CHEMOTHERAPY CLAIM is a disposable device intended for medical purpose, to be worn on the examiners hand or finger to prevent contamination between patient and examiner. The product has been tested with chemotherapy drugs in accordance with ASTM D6978. The breakthrough detection times are as follows: Test Chemotherapy Drug Name and Concentration Minimum Breakthrough Detection Time Carmustine (BCNU) (3.3mg/ml),(3,300 ppm) ● 4.3 Minutes >240 Minutes >240 Minutes >240 Minutes >240 Minutes >240 Minutes >240 Minutes >240 Minutes >240 Minutes >240 Minutes 10.9 Minutes >240 Minutes - Cisplatin(1.0mg/ml), (1,000 ppm) - Cyclophosphamide/Cytoxan(20mg/ml), (20,000 ppm) - Dacarbazine(DTIC) 10mg/ml, (10,000 ppm) ● - Doxorubicin HCL(2mg/ml),(2,000 ppm) - Etoposide /Toposar (20mg/ml), (20,000 ppm) - Fluorouracil(50mg/ml), (50,000 ppm) - Ifosfamide (50mg/ml), (50,000 ppm) - Mitoxantrone(2mg/ml),(2,000 ppm) - Paclitaxel(6.0mg/ml),(6,000 ppm) - Thiotepa (10mg/ml),(10,000 ppm) - . Vincristine Sulfate(1.0mg/ml),(1,000 ppm) Please note that Carmustine and Thiotepa have extremely low permeation times of 4.3 minutes and 10.9 minutes, respectively. Warning: Do not use with Carmustine and Thiotepa.
    Device Description
    The subject device in this 510(k) Notification is Sterling/Grey coloured Nitrile Examination gloves, with claims and tested for use with Chemotherapy drugs. The subject device is a patient examination glove made from nitrile compound, Sterling or Grey in colour, powder free and non sterile (as per 21 CFR 880.6250, class I). The principle operation of the medical device to provide single use barrier protection for the wearer and the device meets all the requirement specifications for Barrier Protection, tensile properties as defined in ASTM D6319-10, Standard specification for Nitrile Examination Gloves. This device also complies with requirements for Standard Practice for Assessment of Resistance of Medical Gloves to Permeation by Chemotherapy drugs as per ASTM D6978-05
    Ask a Question
    K Number
    K163267
    Device Name
    NITRILE EXAMINATION GLOVE
    Manufacturer
    BRIGHTWAY HOLDINGS SDN BHD
    Date Cleared
    2017-03-24

    (123 days)

    Product Code
    LZA
    Regulation Number
    880.6250
    Why did this record match?
    Applicant Name (Manufacturer) :

    BRIGHTWAY HOLDINGS SDN BHD

    AI/MLSaMDIVD (In Vitro Diagnostic)TherapeuticDiagnosticis PCCP Authorized
    Intended Use
    BRIGHTWAY BRAND NITRILE EXAMINATION GLOVES, POWDER FREE, [BLUE] is a disposable device intended for medical purpose to be worn on the examiners hand or finger to prevent contamination between the patient and the examiner.
    Device Description
    The subject device in this 510(k) Notification is a Blue Examination Glove. The subject device is a patient examination glove made from a Nitrile compound, Blue in colour, powder free and non sterile (as per 21 CFR 880.6250, class I). The principle operation of the medical device to provide single use barrier protection for the wearer and the device that meets all the requirement specifications for Barrier Protection, tensile properties as defined in ASTM D6319-10 ; Standard specification for Nitrile Examination Gloves.
    Ask a Question
    K Number
    K162146
    Device Name
    Brightway Brand Nitrile Examination Gloves, Powder Free (Lavender)
    Manufacturer
    BRIGHTWAY HOLDINGS SDN BHD.
    Date Cleared
    2017-01-05

    (157 days)

    Product Code
    LZA
    Regulation Number
    880.6250
    Why did this record match?
    Applicant Name (Manufacturer) :

    BRIGHTWAY HOLDINGS SDN BHD

    AI/MLSaMDIVD (In Vitro Diagnostic)TherapeuticDiagnosticis PCCP Authorized
    Intended Use
    BRIGHTWAY BRAND NITRILE EXAMINATION GLOVES, POWDER FREE, [LAVENDER] is a disposable device intended for medical purpose, to be worn on the examiners hand or finger to prevent contamination between patient and examiner.
    Device Description
    The subject device in this 510(k) Notification is a Lavender Examination Glove. The subject device is a patient examination glove made from a Nitrile compound, Lavender in colour, powder free and non sterile (as per 21 CFR 880.6250, class I). The principle operation of the medical device to provide single use barrier protection for the wearer and the device that meets all the requirement specifications for Barrier Protection, tensile properties as defined in ASTM D6319-10 ; Standard specification for Nitrile Examination Gloves.
    Ask a Question
    K Number
    K161215
    Device Name
    Brightway Brand Nitrile Examination Gloves, Powder Free, [Sterling/Grey] Tested For Use With Chemotherapy Drugs
    Manufacturer
    BRIGHTWAY HOLDINGS SDN BHD
    Date Cleared
    2016-12-21

    (236 days)

    Product Code
    LZA, LZC
    Regulation Number
    880.6250
    Why did this record match?
    Applicant Name (Manufacturer) :

    BRIGHTWAY HOLDINGS SDN BHD

    AI/MLSaMDIVD (In Vitro Diagnostic)TherapeuticDiagnosticis PCCP Authorized
    Intended Use
    BRIGHTWAY BRAND NITRILE EXAMINATION GLOVES, POWDER FREE, [STERLING/GREY] TESTED FOR USE WITH CHEMOTHERAPHY DRUGS is a disposable device intended for medical purpose worn on the examiners hand or finger to prevent contamination between patient and examiner. The tested chemotherapy drugs and their breakthrough detection times are as follows: Test Chemotherapy Drug Name and Concentration - · Carmustine (BCNU) (3.3mg/ml),(3.300 ppm) - · Cisplatin(1.0mg/ml), (1,000 ppm) - · Cyclophosphamide/Cytoxan(20mg/ml), (20,000 ppm) - · Dacarbazine(DTIC) 10mg/ml, (10,000 ppm) - · Doxorubicin HCL(2mg/ml),(2,000 ppm) - · Etoposide /Toposar (20mg/ml), (20,000 ppm) - · Fluorouracil(50mg/ml), (50,000 ppm) - · Ifosfamide (50mg/ml), (50,000 ppm) - · Mitoxantrone(2mg/ml),(2,000 ppm) - · Paclitaxel/Taxol(6.0mg/ml),(6.000 ppm) - · Thiotepa (10mg/ml),(10,000 ppm) - · Vincristine Sulfate(1.0mg/ml),(1,000 ppm) Please note that the following drugs have extremely low permeation times: Carmustine (BCNU) 5.4 minutes and Thiotepa 40.4 minutes. Minimum Breakthrough Detection Time 5.4 Minutes >240 Minutes >240 Minutes >240 Minutes >240 Minutes >240 Minutes >240 Minutes >240 Minutes >240 Minutes >240 Minutes 40.4 Minutes >240 Minutes
    Device Description
    The subject device in this 510(k) Notification is a Sterling/Grey Nitrile Examination gloves, with claims and tested for use with Chemotherapy drugs. The subject device is a patient examination glove made from nitrile compound, Sterling or Grev in color, powder free and non sterile (as per 21 CFR 880.6250, class I). The principle operation of the medical device to provide single use barrier protection for the wearer and the device meets all the requirement specifications for Barrier Protection, tensile properties as defined in ASTM D6319-10, Standard specification for Nitrile Examination Gloves. This device is manufactured in facilities compliant to ISO 9001:2008 certified in Manufacture of Non Sterile Natural (Latex) and Synthetic Latex (Nitrile) Examination, Surgical and Industrial Gloves & Nitrile Sheath The device is manufactured to comply with ISO 13485:2003 / EN ISO 13485:2012 Manufacture of Non Sterile Natural (Latex) and Synthetic Latex (Nitrile) Examination & Sterile Surgical Gloves
    Ask a Question

    Page 1 of 1